Results 71 to 80 of about 3,798,723 (244)

Protective effects and mechanisms of high-dose vitamin C on sepsis-associated cognitive impairment in rats [PDF]

, 2021
Ning Zhang, Wei Zhao, Zhenjie Hu, Shengmei Ge, Yan Huo, Lixia Liu, Bu-Lang Gao   +6 more
openalex   +1 more source

Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis [PDF]

, 2022
Igor Diemberger, Stefano Fumagalli, A. Mazzone, Ameet Bakhai, Paul Egbert Reimitz, Ladislav Pecen, Marius Constantin Manu, José Souza, Paulus Kirchhof, Raffaele De Caterina   +9 more
openalex   +1 more source

Patient acceptability, safety and access : A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations [PDF]

, 2018
© 2017 Elsevier B.V. All rights reserved.The selection and design of age-appropriate formulations intended for use in paediatric and geriatric patients are dependent on multiple factors affecting patient acceptability, safety and access.
Ernest, Terry B., Liu, Fang, Ranmal, Sejal R., Walsh, Jennifer   +3 more
core   +2 more sources

Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients

Transplant International
Valganciclovir (VGC) is administered as prophylaxis to kidney transplant recipients (KTR) CMV donor (D)+/recipient (R)− and CMV R+ after thymoglobulin-induction (R+/TG).
Nathalie Hammer, Linard Hoessly, Fadi Haidar, Cédric Hirzel, Sophie de Seigneux, Christian van Delden, Bruno Vogt, Daniel Sidler, Dionysios Neofytos   +8 more
doaj   +1 more source

Mound Systems: Pressure Distribution of Wastewater: Design and Construction in Ohio [PDF]

, 1992
PDF pages ...
Gustafson, Robert, Mancl, Karen M.
core  

Fixed Dosing of Monoclonal Antibodies in Oncology

The Oncologist, 2017
In the field of oncology, most drugs are administered in a body–size‐based dosing schedule instead of a fixed dose for all patients. This article presents the advantages of fixed dosing of monoclonal antibodies, arguing in favor of fixed dosing schemes ...
J. Hendrikx, J. Haanen, E. Voest, J. Schellens, A. Huitema, J. Beijnen   +5 more
semanticscholar   +1 more source

Phage therapy dosing: The problem(s) with multiplicity of infection (MOI)

Bacteriophage, 2016
The concept of bacteriophage multiplicity of infection (MOI) – ratios of phages to bacteria – historically has been less easily applied than many phage workers would prefer or, perhaps, may be aware.
S. Abedon
semanticscholar   +1 more source

Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis. [PDF]

, 2018
BackgroundContinuous-infusion 5-fluorouracil (5FU) and calcium leucovorin plus nab-paclitaxel and oxaliplatin have been shown to be active in patients with pancreatic cancer.
Bedford, Rudolph, Donahue, Timothy, Hines, O Joe, Hoos, William, Isacoff, William H, Rahib, Lola, Reber, Howard A, Upfill-Brown, Alexander   +7 more
core   +1 more source

Sand Bioreactors for Wastewater Treatment for Ohio Communities [PDF]

, 1999
PDF pages ...
Mancl, Karen M., Rector, Don
core  

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy. [PDF]

, 2002
In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g x kg(-1) x wk(-1) or to a control group receiving epoetin alfa at an initial dose of 150 U x kg(-1) three times weekly.
Armstrong, S, Colowick, AB, Glaspy, JA, Jadeja, JS, Justice, G, Kessler, J, O'Byrne, J, Richards, D, Rossi, G, Schwartzberg, L, Tchekmedyian, NS   +10 more
core   +2 more sources